[
  {
    "title": "J&J to Invest $55B in United States to Boost Manufacturing, R&D",
    "published": 1742812140,
    "posting_price": 26.10000038,
    "close_price": 25.92499924,
    "percent_change": -0.67050244
  },
  {
    "title": "China touts business potential to US companies despite 'rising instability'",
    "published": 1742776921,
    "posting_price": 26.10000038,
    "close_price": 25.92499924,
    "percent_change": -0.67050244
  },
  {
    "title": "Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio",
    "published": 1742587997,
    "posting_price": 26.12999916,
    "close_price": 26.28000069,
    "percent_change": 0.57405869
  },
  {
    "title": "Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug",
    "published": 1742580248,
    "posting_price": 26.12999916,
    "close_price": 26.28000069,
    "percent_change": 0.57405869
  },
  {
    "title": "Trump Trade: Reciprocal tariffs still to start on April 2",
    "published": 1742479258,
    "posting_price": 26.25,
    "close_price": 26.19000053,
    "percent_change": -0.22856941
  },
  {
    "title": "Why the Market Dipped But Pfizer (PFE) Gained Today",
    "published": 1713217522,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Pfizer Eyeing Viking Therapeutics? A Scenario Among All The M&A Talk",
    "published": 1713197290,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Is Pfizer Stock a Buy?",
    "published": 1713185100,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call",
    "published": 1713181800,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Want $1,000 in Annual Dividend Income? Invest $13,200 in These Ultra-High-Yield Dividend Stocks.",
    "published": 1713171180,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "A Closer Look at Pfizer's Options Market Dynamics",
    "published": 1713171060,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Skanska announces decreased scope for facility in Everett, Washington, USA, worth USD 49M, about SEK 510M",
    "published": 1713169161,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Morning Brew: Tech Giants Navigate Regulatory Hurdles",
    "published": 1713166260,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)",
    "published": 1713163260,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push",
    "published": 1713156540,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Noteworthy Monday Option Activity: PFE, TOL, OKTA",
    "published": 1713147480,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "Pfizer call volume above normal and directionally bullish",
    "published": 1713144360,
    "posting_price": 24.38178635,
    "close_price": 24.38178635,
    "percent_change": 0.0
  },
  {
    "title": "10 Micro-Cap Healthcare Stocks Insiders Are Buying",
    "published": 1713121228
  },
  {
    "title": "Large Fund Bets Big on Groceries in the Face of Persistent Inflation",
    "published": 1713078000
  },
  {
    "title": "Two Brothers, a Big Biotech Bet and an $8 Billion Payout",
    "published": 1713016800
  },
  {
    "title": "AbbVie keeps Humira market share near 100% despite biosimilars: report",
    "published": 1713002160
  },
  {
    "title": "The Smartest Dividend Stocks to Buy With $400 Right Now",
    "published": 1713001620
  },
  {
    "title": "Big Pharma: Investment Bedrock",
    "published": 1712961000,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Pfizer's Innovative Drug Pipeline Provides Ample Reason To Buy It Here",
    "published": 1712935833,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Zentalis Pharmaceuticals: Data In 1st Half Of 2024 Could Get The Ball Rolling",
    "published": 1712931143,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News",
    "published": 1712928120,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever",
    "published": 1712916420,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Is Pfizer Stock the Biggest Bargain in the S&P 500?",
    "published": 1712915400,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Obesity-drug power couple Novo Nordisk and Eli Lilly still have room to run, analysts say",
    "published": 1712909640,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Biogen Is Suffering From Doubts About the Future",
    "published": 1712908860,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Morning Brew: Tech Giants Lead Market Movements Amid Earnings Anticipation",
    "published": 1712907060,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Healthpeak Properties: A Quality Healthcare REIT That Should Get Back To Dividend Growth",
    "published": 1712905200,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "U.S. Wide-Moat Stocks On Sale - The April 2024 Heat Map",
    "published": 1712898708,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "Pfizer\u2019s Hold Rating Upheld Amid Modest Sales Outperformance and Market Uncertainty",
    "published": 1712896020,
    "posting_price": 24.7017344,
    "close_price": 24.33473778,
    "percent_change": -1.48571195
  },
  {
    "title": "If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names",
    "published": 1712857753,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer: The Market Is Wrong",
    "published": 1712847604,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?",
    "published": 1712841120,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Will Pfizer's (PFE) New Drugs Provide a Boost to 2024 Sales?",
    "published": 1712841120,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly",
    "published": 1712838960,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "The Zacks Analyst Blog Highlights UnitedHealth, Pfizer, BlackRock, The Hershey and Edison International",
    "published": 1712837940,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer unit to settle Effexor XR antitrust claims in $39M deal",
    "published": 1712830680,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "BUZZ Investing: Echoes Of 'Mission Accomplished' Amid Inflation Battle",
    "published": 1712830500,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25",
    "published": 1712829907,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Interesting PFE Put And Call Options For May 31st",
    "published": 1712828400,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Alkermes' Innovations Are Transforming Mental Health Treatments",
    "published": 1712822460,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Notable open interest changes for April 11th",
    "published": 1712822160,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Morning Brew: Tesla's New Model Sparks Investor Interest",
    "published": 1712822100,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Parnassus Value Equity Fund's Strategic Moves: Spotlight on Amdocs Ltd with a -1.7% Impact",
    "published": 1712808120,
    "posting_price": 24.79583694,
    "close_price": 24.78642654,
    "percent_change": -0.03795153
  },
  {
    "title": "Top Analyst Reports for UnitedHealth, Pfizer & BlackRock",
    "published": 1712776020,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape",
    "published": 1712769738,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "The Pharmaceutical Industry Finds Itself At A Historical Crossroads",
    "published": 1712767671,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal",
    "published": 1712755560,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "ClearBridge Appreciation Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712753700,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Pfizer (PFE) Receives a Hold from Berenberg Bank",
    "published": 1712747700,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "New additions to Goldman\u2019s High Operating Leverage list",
    "published": 1712746860,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO in Adults Aged 18 to 59 at Increased Risk for RSV Disease",
    "published": 1712744083,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE) and Fusion Pharmaceuticals (FUSN)",
    "published": 1712730660,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Where Will Pfizer Stock Be in 10 Years?",
    "published": 1712729160,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "PM Fumio Kishida Urges US Tech Giants To Invest In Japan: 'I'm Strongly Promoting Policies Toward The Next Economic Stage'",
    "published": 1712723340,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Pfizer\u2019s Hold Rating Balances Vaccine Growth Potential with Competitive and Financial Challenges",
    "published": 1712721480,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says",
    "published": 1712713620,
    "posting_price": 24.95581115,
    "close_price": 24.76760674,
    "percent_change": -0.75415064
  },
  {
    "title": "Pfizer unveils positive phase 3 trial results for RSV Vaccine",
    "published": 1712697285,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "NEW YORK MARKET CLOSE: Stocks mixed in choppy trade ahead of CPI data",
    "published": 1712679300,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV Vaccine Could Get Wider Use. New Study Suggests a Benefit For All Adults.",
    "published": 1712674440,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer : March Social Media Round-Up\u2014Annual Review, International Women\u2019s Day, and a School of Science Celebration",
    "published": 1712674269,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Tempus Releases New Data at AACR Showcasing Ways to Analyze Multimodal Data to Highlight Potential Therapeutic Routes for HER2- Directed Antibody-Drug Conjugates in Several Tumor Types",
    "published": 1712670803,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV treatment meets targets in trial of adults under age 60",
    "published": 1712670060,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "2 Ultra-High-Yield Dividend Stocks to Buy and Hold Forever",
    "published": 1712664900,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer, with new study results, seeks to bring RSV shot to adults aged 18-59",
    "published": 1712664600,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Novo Nordisk: The Moat Won't Last Forever",
    "published": 1712662210,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer Seeks Expanded Use Of Abrysvo As Vaccine Shows Potential In 18+ Patients",
    "published": 1712661960,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV shot meets goals in trial of high-risk adults under age 60",
    "published": 1712659650,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO\u00ae in Adults Aged 18 to 59 at Increased Risk for RSV Disease",
    "published": 1712659500,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Billionaire Ken Griffin Loaded Up on This High-Yield Dividend Stock. Should You?",
    "published": 1712656200,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Decoding Pfizer's Options Activity: What's the Big Picture?",
    "published": 1712653380,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer: positive results for RSV in adults",
    "published": 1712651018,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer's Abrysvo Hits Key Goals in Adults at Increased RSV Risk",
    "published": 1712646020,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer RSV shot meets key goal in trial of high-risk adults under age 60",
    "published": 1712643900,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Asian Markets Trend Upwards Amid Anticipation for Inflation Data and Federal Reserve's Next Move",
    "published": 1712643480,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Pfizer's Abrysvo meets primary Phase 3 endpoint in RSV disease",
    "published": 1712641860,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Upcoming Catalysts Position Perrigo For Sustained Long-Term Dividend Growth",
    "published": 1712641773,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "3 Dirt-Cheap Stocks That Could Make You Filthy Rich",
    "published": 1712639940,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "Election Year Encore: Can 2020\u2019s Top 7 Stock Winners Repeat Their Performance in 2024?",
    "published": 1712633820,
    "posting_price": 25.19106529,
    "close_price": 25.20047569,
    "percent_change": 0.0373561
  },
  {
    "title": "20 Most Populated Counties in the US",
    "published": 1712613441,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Pfizer (PFE) Declines More Than Market: Some Information for Investors",
    "published": 1712612720,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering Manager",
    "published": 1712594640,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Is Trending Stock Pfizer Inc. (PFE) a Buy Now?",
    "published": 1712581217,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "GSK, Pfizer-backed ViiV gets FDA okay for HIV drug for adolescents",
    "published": 1712575080,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Why Is Ocugen (OCGN) Stock Up 7% Today?",
    "published": 1712570460,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "This S&P 500 Dividend Stock Could Be the Best Bad-News Buy on the Market",
    "published": 1712569620,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead",
    "published": 1712567160,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV",
    "published": 1712564580,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Notable open interest changes for April 8th",
    "published": 1712562960,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Amazon, Alphabet And A Pharmaceutical Giant: CNBC's 'Final Trades'",
    "published": 1712562060,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "ViiV Healthcare announces FDA approval of Dovato for adolescents with HIV",
    "published": 1712560440,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "The 3 Most Undervalued Healthcare Stocks to Buy in April 2024",
    "published": 1712559960,
    "posting_price": 25.03109077,
    "close_price": 25.01226997,
    "percent_change": -0.07518969
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stocks",
    "published": 1712493540
  },
  {
    "title": "Morgan Stanley sees Fed rate cut fueling biotech stock performance",
    "published": 1712493180
  },
  {
    "title": "My Top-5 Ultrahigh-Yield Dividend Stocks to Buy in April",
    "published": 1712483220
  },
  {
    "title": "Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst",
    "published": 1712473500
  },
  {
    "title": "Jury sides with SEC in trial over insider trading charges against former pharma executive",
    "published": 1712401200
  },
  {
    "title": "3 No-Brainer Dividend Stocks to Buy in April",
    "published": 1712400540
  },
  {
    "title": "5 Relatively Secure And Cheap Dividend Stocks To Invest In - April 2024",
    "published": 1712395800
  },
  {
    "title": "ClearBridge Dividend Strategy Q1 2024 Portfolio Manager Commentary",
    "published": 1712385900
  },
  {
    "title": "The 3 Most Undervalued Biotech Stocks to Buy in April 2024",
    "published": 1712321820,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Pfizer's Paxlovid Demonstrates Safety But Raises Questions on Efficacy in Low-Risk Covid-19 Patients-NEJM Study",
    "published": 1712320380,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Analysts\u2019 Top Healthcare Picks: Pfizer (PFE), Eli Lilly & Co (LLY)",
    "published": 1712316060,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income",
    "published": 1712311920,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Working to \u201cOutdo\u201d Cancer: A Multi-Modality Approach to Accelerating the Next Generation of Cancer Breakthroughs",
    "published": 1712309887,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "Pfizer Inc. stock rises Friday, still underperforms market",
    "published": 1712288700,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024",
    "published": 1712288220,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "3 Healthcare Stocks Short Sellers Are Prescribing for Trouble",
    "published": 1712281200,
    "posting_price": 24.99344892,
    "close_price": 25.08755112,
    "percent_change": 0.37650746
  },
  {
    "title": "10 Health Care Stocks Whale Activity In Today's Session",
    "published": 1712234280,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster",
    "published": 1712218980,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Viatris- Theramex deal for women's care products raises antitrust concerns in U.K.",
    "published": 1712217600,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "CCI, PFE: 2 High-Yield Dividend Stocks to Buy, According to Analysts",
    "published": 1712213100,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Sanofi to Resolve 4,000 Zantac Cancer Lawsuits in US Courts",
    "published": 1712209440,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.",
    "published": 1712206800,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "The Comeback Kids: 7 Stocks Ready to Rise from the Ashes",
    "published": 1712201760,
    "posting_price": 25.69921422,
    "close_price": 25.07814217,
    "percent_change": -2.41669665
  },
  {
    "title": "How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings",
    "published": 1712149209,
    "posting_price": 25.88741723,
    "close_price": 25.61452103,
    "percent_change": -1.05416542
  },
  {
    "title": "Jefferies sees Roivant rallying 5%-10% on today's COVID patent order",
    "published": 1712149020,
    "posting_price": 25.88741723,
    "close_price": 25.61452103,
    "percent_change": -1.05416542
  },
  {
    "title": "2 Strong Dividend Buys And 2 Sells For Q2 2024",
    "published": 1712139180,
    "posting_price": 25.88741723,
    "close_price": 25.61452103,
    "percent_change": -1.05416542
  },
  {
    "title": "Why Investors Need to Take Advantage of These 2 Medical Stocks Now",
    "published": 1712062812,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts",
    "published": 1712056740,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April",
    "published": 1712049660,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era",
    "published": 1712049480,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "AstraZeneca CEO Highlights Decade-Long Sales Goal Of $45B Along With Investor Doubts As It Lags In Weight Loss Race",
    "published": 1712022900,
    "posting_price": 25.94387726,
    "close_price": 25.92505646,
    "percent_change": -0.07254428
  },
  {
    "title": "Pfizer (PFE) Stock Moves -0.11%: What You Should Know",
    "published": 1712007921,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Unbeatable Blue Chips: 7 Must-Own Stocks for Every Portfolio",
    "published": 1712003400,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "US scientists are leaving academia. That\u2019s bad news for drug companies",
    "published": 1711978144,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study",
    "published": 1711989960,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "2 Stocks Down 30% and 27% to Buy and Hold",
    "published": 1711980900,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Three Stocks That Are Set Up For A Great Second Quarter Of 2024",
    "published": 1711975920,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Blue-Chip Bulldozers: 7 Stock Giants to Plow Through a Wall of Worries",
    "published": 1711975860,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "5 FDA decisions to watch in the second quarter",
    "published": 1711972560,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "What You Missed On Wall Street This Morning",
    "published": 1711969800,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "The Kinetix Group and Pfizer Health Equity Work Recognized by PM360",
    "published": 1711966122,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Thinking about trading options or stock in NVIDIA, Trump Media & Technology, Microsoft, Enterprise Products Partners, or Pfizer?",
    "published": 1711963931,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Solid Biosciences gets FDA rare pediatric disease status for DMD therapy",
    "published": 1711963200,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Better Recovery Story Buy: Pfizer vs Moderna",
    "published": 1711962300,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Jim Cramer Says Chevron Is Doing 'Pretty Well,' Will Give This Pharma Giant 'A Chance'",
    "published": 1711958700,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "What You Missed On Wall Street On Monday",
    "published": 1711941540,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  },
  {
    "title": "Healthcare And Biotech Stocks Review: Q1 2024 Performance",
    "published": 1711940880,
    "posting_price": 26.12267311,
    "close_price": 26.08503151,
    "percent_change": -0.14409551
  }
]